 | • レポートコード：20QY06-08463 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、麻疹・おたふく風邪・風疹（MMR）用ワクチンのグローバル市場について種類別（一価ワクチン、多価ワクチン）、用途別（免疫センター、ワクチン開発機関および組織、病院、研究所、バイオテクノロジーおよびバイオ医薬品企業）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・麻疹・おたふく風邪・風疹（MMR）用ワクチン市場の概要 ・世界の主要地域別麻疹・おたふく風邪・風疹（MMR）用ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の麻疹・おたふく風邪・風疹（MMR）用ワクチン市場規模2015-2026：種類別（一価ワクチン、多価ワクチン） ・世界の麻疹・おたふく風邪・風疹（MMR）用ワクチン市場規模2015-2026：用途別（免疫センター、ワクチン開発機関および組織、病院、研究所、バイオテクノロジーおよびバイオ医薬品企業） ・麻疹・おたふく風邪・風疹（MMR）用ワクチンの北米市場規模2015-2020 ・麻疹・おたふく風邪・風疹（MMR）用ワクチンのヨーロッパ市場規模2015-2020 ・麻疹・おたふく風邪・風疹（MMR）用ワクチンの中国市場規模2015-2020 ・麻疹・おたふく風邪・風疹（MMR）用ワクチンの日本市場規模2015-2020 ・麻疹・おたふく風邪・風疹（MMR）用ワクチンの東南アジア市場規模2015-2020 ・麻疹・おたふく風邪・風疹（MMR）用ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Medlmmune、Johnson & Johnson、Merck、Sanofi、Serum、Bavarian Nordic、Astellas Pharma、Emergent BioSolutions、GlaxoSmithKline、Pfizer、CSL） ・麻疹・おたふく風邪・風疹（MMR）用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・麻疹・おたふく風邪・風疹（MMR）用ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Measles, Mumps and Rubella (MMR) Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Measles, Mumps and Rubella (MMR) Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Measles, Mumps and Rubella (MMR) Vaccines industry.
Based on our recent survey, we have several different scenarios about the Measles, Mumps and Rubella (MMR) Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Measles, Mumps and Rubella (MMR) Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Measles, Mumps and Rubella (MMR) Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Measles, Mumps and Rubella (MMR) Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Measles, Mumps and Rubella (MMR) Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Measles, Mumps and Rubella (MMR) Vaccines market. The report also includes nautical information, where it shows Measles, Mumps and Rubella (MMR) Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Measles, Mumps and Rubella (MMR) Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Measles, Mumps and Rubella (MMR) Vaccines market.
Geographical Analysis:
Based on region, the global Measles, Mumps and Rubella (MMR) Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Measles, Mumps and Rubella (MMR) Vaccines market are
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
Segment by Type
Monovalent Vaccine
Polyvalent Vaccine
Segment by Application
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Measles, Mumps and Rubella (MMR) Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Measles, Mumps and Rubella (MMR) Vaccines market.
• The market share of the global Measles, Mumps and Rubella (MMR) Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Measles, Mumps and Rubella (MMR) Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Measles, Mumps and Rubella (MMR) Vaccines market.
1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.1 Measles, Mumps and Rubella (MMR) Vaccines Product Scope
1.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2020-2026)
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Measles, Mumps and Rubella (MMR) Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Measles, Mumps and Rubella (MMR) Vaccines Industry
1.5.1.1 Measles, Mumps and Rubella (MMR) Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Measles, Mumps and Rubella (MMR) Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Measles, Mumps and Rubella (MMR) Vaccines Players to Combat Covid-19 Impact
2 Measles, Mumps and Rubella (MMR) Vaccines Estimate and Forecast by Region
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2015-2026)
2.4.3 China Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2015-2026)
2.4.6 India Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2015-2026)
3 Global Measles, Mumps and Rubella (MMR) Vaccines Competition Landscape by Players
3.1 Global Top Measles, Mumps and Rubella (MMR) Vaccines Players by Sales (2015-2020)
3.2 Global Top Measles, Mumps and Rubella (MMR) Vaccines Players by Revenue (2015-2020)
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2019)
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Measles, Mumps and Rubella (MMR) Vaccines Players (Opinion Leaders)
4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2014-2020)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Type (2021-2026)
5 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2015-2020)
5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2021-2026)
3 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
3.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
4 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
4.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
5 China Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
5.2 China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
5.3 China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
5.4 China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
6 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
6.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
7.2 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
8 India Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
8.2 India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
8.3 India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
8.4 India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Measles, Mumps and Rubella (MMR) Vaccines Business
12.1 Medlmmune
12.1.1 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.1.2 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.1.5 Medlmmune Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.2.2 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.3.2 Merck Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.4.2 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.4.5 Sanofi Recent Development
12.5 Serum
12.5.1 Serum Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.5.2 Serum Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.5.5 Serum Recent Development
12.6 Bavarian Nordic
12.6.1 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.6.2 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.6.5 Bavarian Nordic Recent Development
12.7 Astellas Pharma
12.7.1 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.7.2 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.7.5 Astellas Pharma Recent Development
12.8 Emergent BioSolutions
12.8.1 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.8.2 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.8.5 Emergent BioSolutions Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.9.2 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Pfizer
12.10.1 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.10.2 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.10.5 Pfizer Recent Development
12.11 CSL
12.11.1 CSL Measles, Mumps and Rubella (MMR) Vaccines Corporation Information
12.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Business Overview and Total Revenue
12.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.11.5 CSL Recent Development
13 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Cost Analysis
13.1 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines
13.4 Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors List
14.3 Measles, Mumps and Rubella (MMR) Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Measles, Mumps and Rubella (MMR) Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Measles, Mumps and Rubella (MMR) Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Measles, Mumps and Rubella (MMR) Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Region (2015-2020)
Table 10. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines (K Doses) of Key Companies (2015-2020)
Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Company (2015-2020)
Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2019)
Table 22. Global Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Measles, Mumps and Rubella (MMR) Vaccines Players
Table 27. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 28. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2015-2020)
Table 29. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Type (2015-2020)
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2021-2026)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Type (2021-2026)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2015-2020)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Application (2015-2020)
Table 39. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2021-2026)
Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2021-2026)
Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Application (2021-2026)
Table 44. United States Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2015-2020)
Table 45. United States Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 47. United States Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2015-2020)
Table 51. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 53. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)
Table 55. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2015-2020)
Table 57. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 59. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)
Table 61. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2015-2020)
Table 63. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 65. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)
Table 67. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2015-2020)
Table 75. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)
Table 77. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)
Table 79. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
Table 80. Medlmmune Corporation Information
Table 81. Medlmmune Description and Business Overview
Table 82. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product
Table 84. Medlmmune Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product
Table 89. Johnson & Johnson Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Merck Measles, Mumps and Rubella (MMR) Vaccines Product
Table 94. Merck Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product
Table 99. Sanofi Recent Development
Table 100. Serum Corporation Information
Table 101. Serum Description and Business Overview
Table 102. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Serum Measles, Mumps and Rubella (MMR) Vaccines Product
Table 104. Serum Recent Development
Table 105. Bavarian Nordic Corporation Information
Table 106. Bavarian Nordic Description and Business Overview
Table 107. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product
Table 109. Bavarian Nordic Recent Development
Table 110. Astellas Pharma Corporation Information
Table 111. Astellas Pharma Description and Business Overview
Table 112. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product
Table 114. Astellas Pharma Recent Development
Table 115. Emergent BioSolutions Corporation Information
Table 116. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Emergent BioSolutions Description and Business Overview
Table 118. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product
Table 119. Emergent BioSolutions Recent Development
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. GlaxoSmithKline Description and Business Overview
Table 123. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product
Table 124. GlaxoSmithKline Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product
Table 129. Pfizer Recent Development
Table . CSL Corporation Information
Table . CSL Description and Business Overview
Table . CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . CSL Measles, Mumps and Rubella (MMR) Vaccines Product
Table . CSL Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 138. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Product Picture
Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application in 2020 & 2026
Figure 6. Immune Center Examples
Figure 7. Vaccine Development Agencies and Organizations Examples
Figure 8. Hospital Examples
Figure 9. Laboratory Examples
Figure 10. Biotechnology and Biopharmaceutical Companies Examples
Figure 11. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 18. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Measles, Mumps and Rubella (MMR) Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Measles, Mumps and Rubella (MMR) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Measles, Mumps and Rubella (MMR) Vaccines Players Market Share by Revenue in Measles, Mumps and Rubella (MMR) Vaccines 2015 & 2019
Figure 29. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2015-2020)
Figure 31. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2015-2020)
Figure 33. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 35. United States Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 36. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company in 2019
Figure 37. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 38. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019
Figure 39. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company in 2019
Figure 40. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 41. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019
Figure 42. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company in 2019
Figure 43. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 44. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019
Figure 45. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company in 2019
Figure 46. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 47. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019
Figure 48. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company in 2019
Figure 49. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2019
Figure 50. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019
Figure 51. Medlmmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Measles, Mumps and Rubella (MMR) Vaccines
Figure 64. Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines
Figure 65. Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
おたふく風邪用薬の世界市場レポート2020 Market Analysis and Insights: Global Mumps Drug Market The global Mumps Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Mumps Drug Scope and Market Size The global Mumps Drug market is segmented by T…- ムンプスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Mumps market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mumps market report provides a detailed…
- ムンプスウイルス検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Mumps Virus Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mumps Virus Testing marke…
- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…